This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Janelle Waite - Innovator in Antibody Development
Introduction
Janelle Waite is a prominent inventor known for her contributions to the field of biotechnology. She has made significant strides in the development of innovative therapies, particularly in the area of antibodies. Her work is instrumental in advancing medical treatments and improving patient outcomes.
Latest Patents
Janelle Waite holds a patent for "Bispecific Anti-MUC16 x Anti-CD28 Antibodies and Uses Thereof." This patent represents her innovative approach to creating bispecific antibodies that can target specific cancer cells, showcasing her expertise in antibody engineering.
Career Highlights
Janelle is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to push the boundaries of scientific research and development. Her role at Regeneron allows her to collaborate with leading experts in the field and contribute to groundbreaking projects.
Collaborations
One of her notable collaborators is Dimitris Skokos. Together, they work on advancing the understanding and application of antibody therapies, further enhancing the potential for innovative treatments in oncology.
Conclusion
Janelle Waite's contributions to the field of biotechnology, particularly through her patent and work at Regeneron Pharmaceuticals, highlight her as a key figure in the development of novel therapeutic solutions. Her dedication to innovation continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile